These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9365536

  • 1. Molecular mechanisms of melanoma metastasis.
    Bar-Eli M.
    J Cell Physiol; 1997 Nov; 173(2):275-8. PubMed ID: 9365536
    [Abstract] [Full Text] [Related]

  • 2. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
    Huang S, Luca M, Gutman M, McConkey DJ, Langley KE, Lyman SD, Bar-Eli M.
    Oncogene; 1996 Dec 05; 13(11):2339-47. PubMed ID: 8957075
    [Abstract] [Full Text] [Related]

  • 3. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
    Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP, Bar-Eli M.
    Cancer Res; 1997 Jun 01; 57(11):2295-303. PubMed ID: 9187135
    [Abstract] [Full Text] [Related]

  • 4. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S, Price JE, Luca M, Jean D, Ronai Z, Bar-Eli M.
    Oncogene; 1997 Oct 23; 15(17):2069-75. PubMed ID: 9366524
    [Abstract] [Full Text] [Related]

  • 5. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
    Woenckhaus C, Giebel J, Failing K, Fenic I, Dittberner T, Poetsch M.
    J Pathol; 2003 Oct 23; 201(2):278-87. PubMed ID: 14517845
    [Abstract] [Full Text] [Related]

  • 6. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.
    Huang S, Jean D, Luca M, Tainsky MA, Bar-Eli M.
    EMBO J; 1998 Aug 03; 17(15):4358-69. PubMed ID: 9687504
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H, Baril P, Tabone E, Bérard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L.
    Cancer Res; 2000 Oct 15; 60(20):5848-56. PubMed ID: 11059782
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular changes in human melanoma metastasis.
    Luca MR, Bar-Eli M.
    Histol Histopathol; 1998 Oct 15; 13(4):1225-31. PubMed ID: 9810513
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gene regulation in melanoma progression by the AP-2 transcription factor.
    Bar-Eli M.
    Pigment Cell Res; 2001 Apr 15; 14(2):78-85. PubMed ID: 11310795
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
    Pickl WF, Majdic O, Fischer GF, Petzelbauer P, Faé I, Waclavicek M, Stöckl J, Scheinecker C, Vidicki T, Aschauer H, Johnson JP, Knapp W.
    J Immunol; 1997 Mar 01; 158(5):2107-15. PubMed ID: 9036955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.